Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
A key highlight will be Brenntag’s qualified amino acids portfolio
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
Subscribe To Our Newsletter & Stay Updated
